These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8892668)

  • 1. Thrombocytemia and abnormal megakaryopoiesis associated with abnormality of chromosome 1p34 in myelodysplastic syndromes.
    Jondeau K; Bouscary D; Viguié F; Picard F; Melle J; Lopez I; Fontenay-Roupie M; Dreyfus F
    Leukemia; 1996 Nov; 10(11):1692-5. PubMed ID: 8892668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
    D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in myelodysplastic syndromes.
    Alfaro R; Pérez-Granero A; Durán MA; Besalduch J; Rosell J; Bernués M
    Leuk Res; 2008 Jan; 32(1):159-61. PubMed ID: 17509681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chromosome 1 pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: report of 2 new cases.
    Millington K; Hudnall SD; Northup J; Panova N; Velagaleti G
    Exp Mol Pathol; 2008 Apr; 84(2):189-93. PubMed ID: 18339374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
    Michalová K; Musilová J; Zemanová Z
    Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on chromosome aberrations and dyshemopoiesis in myelodysplastic syndromes].
    Jiang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):341-7. PubMed ID: 2151690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
    Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
    Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomes in myelodysplastic syndrome: structural abnormalities of chromosome 11. Czechoslovak MDS Cooperative Group.
    Musilova J; Michalova K; Jarosova M
    Ann Genet; 1989; 32(1):43-6. PubMed ID: 2751248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
    Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
    Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics of myelodysplastic syndromes.
    Mecucci C; La Starza R
    Forum (Genova); 1999; 9(1):4-13. PubMed ID: 10101207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.
    Olney HJ; Le Beau MM
    Leuk Res; 2007 Apr; 31(4):427-34. PubMed ID: 17161457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome.
    Lizcova L; Zemanova Z; Malinova E; Jarosova M; Mejstrikova E; Smisek P; Pospisilova D; Stary J; Michalova K
    Cancer Genet Cytogenet; 2010 Aug; 201(1):52-6. PubMed ID: 20633770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
    Xue YQ; Guo Y; Lin BJ; Zhang GR; Lu DW; Wang MH; Gu YZ; Gong JX; Wang LX
    Chin Med J (Engl); 1989 Sep; 102(9):689-94. PubMed ID: 2517082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of myelodysplastic syndromes.
    Gallagher A; Darley RL; Padua R
    Haematologica; 1997; 82(2):191-204. PubMed ID: 9175327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW; Hettinga AC; Reichard KK
    Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosome 2(p13) is a nonrandomly occurring karyotypic abnormality in myelodysplastic syndrome.
    Bernell P; Hast R; Bröndum-Nielsen K
    Cancer Genet Cytogenet; 1992 Mar; 59(1):97-8. PubMed ID: 1555201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.